The 5T33 model has also contributed early on to the CAR-T therapy field by showing that treatment using NKG2D-targeted CAR-T cells prolonged survival of tumor-bearing mice and induced a tumor-specific memory response (105). The gene discussed is KLRK1; the disease is neoplasm.